Open original FDA record ↗Recall record
- FDA identifier
- Z-0292-2013
- Company in FDA record
- Ethicon, Inc.
- FDA classification date
- Nov 16, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class I
Reason stated in the source
SURGIFLO Hemostatic Matrix Kit & SURGIFLO Hemostatic Matrix Kit with Thrombin have an issue within the packing process where a cut could potentially breach the double Tyvek pouch of the packaging.
Source facts
- Action
- Ethicon Inc. sent an Urgent Product Information letter dated August 21, 2012, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to inspect their inventory to determine if they have any of the affected product. Affected product should be returned for replacement to Stericycle using the enclosed pre-paid shipping label. Customers with questions should call 1-877-384-4266 or contact their Ethicon Biosurgery Sales Representative. For questions regarding this recall call 877-384-4266.
- Initiated
- 2012-08-21
- Root cause
- Packaging
- Terminated
- 2014-09-11
- Distribution
- Worldwide Distribution - USA (nationwide) and the countries of Russia, China, and the European Union.
- Recall number
- Z-0292-2013
- Recall status
- Terminated
- CDRH record ID
- 113490
- FDA classified
- 2012-11-16
- Recall event number
- 63322